January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC), Dartmouth Engineering, and Dartmouth-Hitchcock's Department of Surgery have developed a method to convert a standard linear accelerator (LINAC), used for delivery of radiation therapy cancer treatment, to a FLASH ultra-high-dose rate radiation therapy beam.

January 20, 2021 — Exact Therapeutics, a clinical stage precision medicine company, announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT) across multiple disease conditions.

January 20, 2021 — Esaote North America announces that the MyLab X8 Ultrasound System has now been approved in Canada.

January 19, 2021 — Radiation exposure and side effects related to iodine contrast agents are the two main concerns of contrast enhanced computed tomography (CT) examinations.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources for COVID-19 patients during the start of the pandemic, cardiovascular procedures were severely impacted. The increased costs of caring for COVID patients, personal protective equipment (PPE) and the loss of elective procedure revenue caused a massive financial burden on healthcare providers.

The landscape at the Radiological Society of North America’s 2020 (RSNA20) conference was different for everyone this year — attendees and exhibitors alike — as we all grappled with the third wave of

January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.

January 18, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of 

January 18, 2020) — The Society of Cardiovascular Computed Tomography (SCCT), in collaboration with the North American Society of Cardiovascular Imaging (NASCI), recently released a new expert consensus document on coronary CT imaging of atherosclerotic plaque. 
 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now